AMR – Discover Pharma

Welcome to Discover Pharma! Today is : October 11, 2026

AMR

Manufacturing & Supply Chain
University Hospital Cologne selects Celonic for anti-Pseudomonas antibody manufacturing
University Hospital Cologne has selected Celonic as its CDMO partner [...]

August 13, 2026
Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Calla Lily selected for $50M Wellcome Leap antibiotic programme
Calla Lily Clinical Care has been selected for Wellcome Leap’s [...]

August 12, 2026
Digital & Data,Research & Development,Therapeutic Areas
Fleming Initiative selects AWS to support global antimicrobial resistance platform
The Fleming Initiative has selected Amazon Web Services (AWS) to [...]

July 3, 2026
Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics
PACE launches third funding round to tackle antimicrobial resistance and support innovative therapeutics
PACE (Pathways to Antimicrobial Clinical Efficacy) has launched its third [...]

May 5, 2026
Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas
Shionogi and BioVersys agree €498M licensing deal for NTM drug candidates
Deal gives Shionogi access to BioVersys’ BV500 program targeting serious [...]

May 5, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK